Guaifenesin; Hydrocodone Bitartrate Patent Expiration
Guaifenesin; Hydrocodone Bitartrate is Used for increasing the bioavailability of guaifenesin. It was first introduced by Sovereign Pharmaceuticals Llc
Guaifenesin; Hydrocodone Bitartrate Patents
Given below is the list of patents protecting Guaifenesin; Hydrocodone Bitartrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Obredon | US10105324 | Immediate release oral guaifenesin solution | Nov 13, 2035 | Sovereign Pharms |
| Obredon | US9549907 | Immediate release oral guaifenesin solution | Nov 13, 2035 | Sovereign Pharms |
| Obredon | US9808431 | Immediate release oral guaifenesin solution | Nov 13, 2035 | Sovereign Pharms |
Guaifenesin; Hydrocodone Bitartrate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List